Product Information
NORPACE CR 150 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $4.9062 per EA under NDC 00025274231. Its NADAC has been published 256 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the disopyramide phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Pfizer Inc.NDC
00025274231
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2025
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA018655On Market Since
7/20/1982
Pharmacological Classes
Price Statistics
The NADAC for NORPACE CR 150 MG CAPSULE has been published 256 times since Nov 28, 2013, and over the history we have for it it has risen 90.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9062 per EA |
|---|---|
| All-time high | $4.9062 (Jan 14, 2026) |
| All-time low | $2.5730 (Nov 28, 2013) |
| 52-week high | $4.9062 |
| 52-week low | $4.9062 |
| Median price | $4.1488 |
| Average price | $3.9616 |
| Largest weekly change | +21.9% (Jun 22, 2016) |
| Weeks tracked | 256 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORPACE CR 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NORPACE CR 150 MG CAPSULE, manufactured by Pfizer Inc., is $4.9062 per EA (NDC 00025274231), effective Jan 14, 2026.
How has the price of NORPACE CR 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NORPACE CR 150 MG CAPSULE has risen 90.7%. It has been tracked across 256 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORPACE CR 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for NORPACE CR 150 MG CAPSULE has ranged from a low of $2.5730 (Nov 28, 2013) to a high of $4.9062 (Jan 14, 2026), with a median of $4.1488 per EA.
Are there cheaper alternatives to NORPACE CR 150 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DISOPYRAMIDE 150 MG CAPSULE, is $1.5318 per EA — about 69% below NORPACE CR 150 MG CAPSULE.
Who manufactures NORPACE CR 150 MG CAPSULE?
NORPACE CR 150 MG CAPSULE (NDC 00025274231) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification